Abstract
In this work we estimated the budgetary impact of the samples produced by the biobank of the “Instituto Nacional de Cancerología” (BT-INCan) to set a recuperation fee from the perspective of the Health Ministry of Mexico. The study is an observational retrospective review of the direct medical costs (DMCs) of the processes involved in cryopreservation of the samples collected, on a per sample basis, including materials, laboratory tests, personnel, and administrative costs. Materials and labor costs were determined by information collected from the BT-INCan. DMCs were provided depending on the type of sample: plasma, tissue and biopsy; they were calculated according to the process required to preserve them. Sensitivity analysis was performed using bootstrap. Recuperation costs ranged from 130 to 155 USD. Costs were considered on a 5-year time frame for the maintenance per sample, which is the average time that a sample is kept in the BT-INCan. The cost analysis is perceived as an approximation to the most adequate recuperation fee per sample needed to guarantee the correct development of the BT-INCan. This work provides a basis and valuable information about costs, to enable several health institutions to strategically plan and manage a biobank or even motivate to establish their own biobank.
Similar content being viewed by others
References
Andreasson A, Kiss NB, Juhlin CC, Höög A (2013) Long-term storage of endocrine tissues at—80 °C does not adversely affect RNA quality or overall histomorphology. Biopreserv Biobank 11:366–370
Barbareschi M, Cotrupi S, Guarrera GM (2008) Biobanks: instrumentation, personnel and cost analysis. Pathologica 100:139–148
Basik M, Aguilar-Mahecha A, Rousseau C, Diaz Z, Tejpar S, Spatz A, Greenwood CM, Batist G (2013) Biopsies: next-generation biospecimens for tailoring therapy. Nat Rev Clin Oncol 10:437–450
Caboux E, Plymoth A, Hainaut P (2007) Common minimum technical standards and protocols for biological resource centres dedicated to cancer research. WorkGroup report 2. IARC
Campbell LD, Betsou F, Garcia DL, Giri JG, Pitt KE, Pugh RS, Sexton KC, Skubitz AP, Somiari SB (2012) Development of the ISBER best practices for repositories: collection, storage, retrieval and distribution of biological materials for research. Biopreserv Biobank 10:232–233
Enriquez V, Ruiz-Godoy L (2017) Manual de procedimientos del Biobanco del Instituto Nacional de Cancerología. Unpublished
Henderson GE, Cadigan RJ, Edwards TP, Conlon I, Nelson AG, Evans JP, Davis AM, Zimmer C, Weiner BJ (2013) Characterizing biobank organizations in the U.S.: results from a national survey. Genome Med 5:3
Kap M, Oomen M, Arshad S, de Jong B, Riegman P (2014) Fit for purpose frozen tissue collections by RNA integrity number-based quality control assurance at the Erasmus MC tissue bank. Biopreserv Biobank 12:81–90
Moore HM, Kelly AB, Jewell SD, McShane LM, Clark DP, Greenspan R, Hayes DF, Hainaut P, Kim P, Mansfield EA, Potapova O, Riegman P, Rubinstein Y, Seijo E, Somiari S, Watson P, Weier HU, Zhu C, Vaught J (2011) Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathol 119:92–101
Riegman PH, Morente MM, Betsou F, de Blasio P, Geary P (2008) Marble Arch International Working Group on biobanking for biomedical research. Biobanking for better healthcare. Mol Oncol 2:213–222
Rogers J, Carolin T, Vaught J, Compton C (2011) Biobankonomics: a taxonomy for evaluating the economic benefits of standardized centralized human biobanking for translational research. J Natl Cancer Inst Monogr 2011:32–38
Ruíz-Godoy L, Meneses-García A, Suárez-Roa L, Enriquez V, Lechuga-Rojas R, Reyes-Lira E (2010) Organization of a tumor bank: the experience of the National Cancer Institute of Mexico. Pathobiology 77:147–154
Stevenson HS, Wang Y, Muller R, Edelman DC (2015) Long-term stability of total RNA in RNAstable® as evaluated by expression microarray. Biopreserv Biobank 2:114–122
Vaught J, Rogers J, Carolin T, Compton C (2011) Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank. J Natl Cancer Inst Monogr 2011:24–31
Acknowledgements
The authors appreciate the support of Pedro Arellano, Hector Romero and Gabriel Molina, from the Accounting Department, and Silvia García for secretarial support, all of them from the Instituto Nacional de Cancerología, Mexico.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Ruíz-Godoy, L.M., Baez-Revueltas, F.B., de Lourdes Suarez-Roa, M. et al. A pharmacoeconomic analysis of the collection and preservation of samples in the biobank of the “Instituto Nacional de Cancerología” in Mexico City. Cell Tissue Bank 19, 569–580 (2018). https://doi.org/10.1007/s10561-018-9706-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10561-018-9706-1